3D Global Biotech Inc. (TPEX:6808)

3D Global Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,869	5,131	1,088	1,498	2,143	2,645
Market Cap Growth	62.58%	371.49%	-27.35%	-30.09%	-18.98%	-
Enterprise Value	3,185	4,797	915	1,295	1,901	2,368
Last Close Price	49.70	66.14	19.00	26.32	38.77	47.86
PE Ratio	30.33	55.95	-	-	-	-
PS Ratio	11.91	19.31	52.74	109.79	193.46	199.42
PB Ratio	4.27	5.67	3.71	4.40	5.50	5.89
P/TBV Ratio	4.69	6.28	5.69	6.70	9.03	9.44
P/FCF Ratio	43.42	344.12	-	-	-	-
P/OCF Ratio	39.70	261.08	-	-	-	-
EV/Sales Ratio	9.80	18.05	44.33	94.89	171.68	178.57
EV/EBITDA Ratio	20.90	45.85	-	-	-	-
EV/EBIT Ratio	25.09	54.20	-	-	-	-
EV/FCF Ratio	35.75	321.70	-	-	-	-
Debt / Equity Ratio	0.10	0.09	0.04	0.05	0.06	0.05
Debt / EBITDA Ratio	0.57	0.77	-	-	-	-
Debt / FCF Ratio	0.97	5.69	-	-	-	-
Asset Turnover	0.41	0.39	0.06	0.03	0.02	0.03
Inventory Turnover	2.47	17.14	4.41	5.14	9.16	7.15
Quick Ratio	10.69	15.75	6.34	10.41	15.71	23.46
Current Ratio	11.34	15.93	6.63	10.71	16.04	23.64
Return on Equity (ROE)	19.65%	15.31%	-18.28%	-18.37%	-14.24%	-10.22%
Return on Assets (ROA)	10.08%	8.12%	-11.30%	-10.41%	-8.57%	-6.36%
Return on Capital (ROIC)	10.90%	8.55%	-11.88%	-10.78%	-8.83%	-6.54%
Return on Capital Employed (ROCE)	12.90%	9.00%	-	-	-	-
Earnings Yield	3.46%	1.79%	-5.33%	-4.48%	-2.79%	-1.81%
FCF Yield	2.30%	0.29%	-2.98%	-2.36%	-1.81%	-0.88%
Dividend Yield	1.06%	0.80%	-	-	-	-
Buyback Yield / Dilution	-44.33%	-26.08%	-2.32%	-1.69%	-0.77%	-6.02%
Total Shareholder Return	-43.27%	-25.27%	-2.32%	-1.69%	-0.77%	-6.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.